(Q87424548)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24619381%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

review article

1 reference

title

Microvascular dysfunction and efficacy of PDE5 inhibitors in BPH-LUTS (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24619381%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24619381%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Mary A Cotter

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24619381%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

author name string

Norman E Cameron

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24619381%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Christopher H Fry

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24619381%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Dapo Ilo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24619381%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

publication date

11 March 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24619381%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

published in

Nature Reviews Urology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24619381%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24619381%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24619381%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

page(s)

231-241

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24619381%20AND%20SRC:MED&resulttype=core&format=json

Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care--the Triumph project

10 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Benign Prostatic Hyperplasia and Male Lower Urinary Tract Symptoms: Epidemiology and Risk Factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Lower urinary tract symptoms and erectile dysfunction: co-morbidity or typical "Aging Male" symptoms? Results of the "Cologne Male Survey"

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

The association between lower urinary tract symptoms and erectile dysfunction in four centres: the UrEpik study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Association between Lower Urinary Tract Symptoms and Vascular Risk Factors in Aging Men: The Hallym Aging Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Anatomy, physiology, and pathophysiology of erectile dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

The burden and extent of comorbid conditions in patients with erectile dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Efficacy and safety of tadalafil once daily in the treatment of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: results of an international randomized, double-blind, placebo-controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Efficacy and safety of oral tadalafil in the treatment of men in Canada with erectile dysfunction: a randomized, double-blind, parallel, placebo-controlled clinical trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: pathophysiology and mechanism(s) of action

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

The mechanism of action of phosphodiesterase type 5 inhibitors in the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

PDE5-Is for the Treatment of Concomitant ED and LUTS/BPH.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

The role of phosphodiesterases in bladder pathophysiology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

From endothelial dysfunction to atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Endothelial dysfunction: the common consequence in diabetes and hypertension.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

The link between metabolic abnormalities and endothelial dysfunction in type 2 diabetes: an update

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Endothelial dysfunction in metabolic syndrome: prevalence, pathogenesis and management.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Endothelial dysfunction: a key to the pathophysiology and natural history of peripheral arterial disease?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Antioxidants and endothelial dysfunction in hyperlipidemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Efficient gene expression system using the RTP801 promoter in the corpus cavernosum of high-cholesterol diet-induced erectile dysfunction rats for gene therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Pelvic Ischemia Is Measurable and Symptomatic in Patients with Coronary Artery Disease: A Novel Application of Dynamic Contrast‐Enhanced Magnetic Resonance Imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Gene therapy with an erythropoietin enhancer-mediated, hypoxia-inducible gene expression system in the corpus cavernosum of mice with high-cholesterol diet-induced erectile dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Endothelial dysfunction as a target for prevention of cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Nitric oxide synthases: regulation and function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Neuronal nitric oxide synthase and human vascular regulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Urinary bladder urothelium: molecular sensors of chemical/thermal/mechanical stimuli

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Nitric oxide mediates stretch-induced Ca2+ release via activation of phosphatidylinositol 3-kinase-Akt pathway in smooth muscle

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Overactive and underactive bladder dysfunction is reflected by alterations in urothelial ATP and NO release

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Physiological regulation of penile arteries and veins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

The nerves to blood vessels supplying blood to nerves: the innervation of vasa nervorum

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Pathophysiology of diabetic erectile dysfunction: potential contribution of vasa nervorum and advanced glycation endproducts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Post-challenge hyperglycaemia, nitric oxide production and endothelial dysfunction: the putative role of asymmetric dimethylarginine (ADMA).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Endothelium-dependent vasodilatation is impaired in both microcirculation and macrocirculation during acute hyperglycemia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Oral glucose loading acutely attenuates endothelium-dependent vasodilation in healthy adults without diabetes: an effect prevented by vitamins C and E

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Elevated glucose promotes generation of endothelium-derived vasoconstrictor prostanoids in rabbit aorta

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Impaired tissue perfusion: a pathology common to hypertension, obesity, and diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

31 March 2020

Endothelial dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Nitrergic neurodegeneration in cerebral arteries of streptozotocin-induced diabetic rats: a new insight into diabetic stroke

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Effects of doxazosin on blood flow and mRNA expression of nitric oxide synthase in the spontaneously hypertensive rat genitourinary tract

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Phosphodiesterase type 5 expression in human and rat lower urinary tract tissues and the effect of tadalafil on prostate gland oxygenation in spontaneously hypertensive rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Acute vardenafil administration improves bladder oxygenation in spontaneously hypertensive rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Chronic ischemia increases prostatic smooth muscle contraction in the rabbit

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Testosterone protects from metabolic syndrome-associated prostate inflammation: an experimental study in rabbit

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Testosterone and farnesoid X receptor agonist INT-747 counteract high fat diet-induced bladder alterations in a rabbit model of metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Alteration of urothelial-mediated tone in the ischemic bladder: role of eicosanoids

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Oxidative stress and neurodegeneration in the ischemic overactive bladder

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Place of overactive bladder in male lower urinary tract symptoms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Association of lower urinary tract symptoms and chronic ischaemia of the lower urinary tract in elderly women and men: assessment using colour Doppler ultrasonography

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

alpha-Blockers improve chronic ischaemia of the lower urinary tract in patients with lower urinary tract symptoms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Vascular damage as a risk factor for benign prostatic hyperplasia and erectile dysfunction.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Vascular resistance in the prostate evaluated by colour Doppler ultrasonography: is benign prostatic hyperplasia a vascular disease?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Atherosclerosis as a risk factor for benign prostatic hyperplasia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Effect of Tadalafil on prostate haemodynamics: preliminary evaluation with contrast-enhanced US.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Oxidative stress and neurodegeneration in penile ischaemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Changes of extracellular Na+, K+, Ca2+ and H+ of the ischemic myocardium in pigs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Canine bladder blood flow and oxygenation: changes induced by filling, contraction and outlet obstruction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Cardiac ionic currents and acute ischemia: from channels to arrhythmias

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

The effect of bladder outlet obstruction on tissue oxygen tension and blood flow in the pig bladder

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Changes in bladder wall blood oxygen saturation in the overactive obstructed bladder

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

The effect of anoxia and glucose-free solutions on the contractile response of guinea-pig detrusor strips to intrinsic nerve stimulation and the application of excitatory agonists

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Diabetes causes an early reduction in autonomic ganglion blood flow in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

The effects of cellular hypoxia on contraction and extracellular ion accumulation in isolated human detrusor smooth muscle

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

The actions of metabolic inhibition on human detrusor smooth muscle contractility from stable and unstable bladders

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Normal detrusor is more sensitive than hypertrophied detrusor to in vitro ischemia followed by re-oxygenation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Altered contractility of rabbit penile corpus cavernosum smooth muscle by hypoxia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Investigation of cavernosal smooth muscle dysfunction in low flow priapism using an in vitro model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Does the prostatic vascular system contribute to the development of benign prostatic hyperplasia?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

The in vivo and in vitro effects of hypoxia on pig urethral smooth muscle

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Neuropathologic substrates of ischemic vascular dementia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

The cholinergic system in aging and neuronal degeneration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Rho-kinase, a common final path of various contractile bladder and ureter stimuli

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

A Rho-kinase inhibitor, soluble guanylate cyclase activator and nitric oxide-releasing PDE5 inhibitor: novel approaches to erectile dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Hypoxia upregulates von Hippel-Lindau tumor-suppressor protein through RhoA-dependent activity in renal cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Hypoxia up-regulates hypoxia-inducible factor-1alpha expression through RhoA activation in trophoblast cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Rho kinase: an important mediator of atherosclerosis and vascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Y-27632, a Rho-kinase inhibitor, inhibits proliferation and adrenergic contraction of prostatic smooth muscle cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Vardenafil modulates bladder contractility through cGMP-mediated inhibition of RhoA/Rho kinase signaling pathway in spontaneously hypertensive rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Correlation between benign prostatic hyperplasia and inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Is benign prostatic hyperplasia (BPH) an immune inflammatory disease?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Metabolic syndrome and benign prostatic hyperplasia: evidence of a potential relationship, hypothesized etiology, and prevention

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

The correlation between metabolic syndrome and prostatic diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Mechanism of action of phosphodiesterase type 5 inhibition in metabolic syndrome-associated prostate alterations: an experimental study in the rabbit

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

PDE5 inhibitors blunt inflammation in human BPH: a potential mechanism of action for PDE5 inhibitors in LUTS.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Vascular consequences of intermittent hypoxia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

The effect of aging on endoneurial blood flow, hyperemic response and oxygen-free radicals in rat sciatic nerve

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Synergistic action of advanced glycation end products and endogenous nitric oxide leads to neuronal apoptosis in vitro: a new insight into selective nitrergic neuropathy in diabetes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Loss of nitric oxide and endothelial-derived hyperpolarizing factor-mediated responses in aging.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

The influence of dose of microspheres on nerve blood flow, electrophysiology, and fiber degeneration of rat peripheral nerve

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Impairment of both nitric oxide-mediated and EDHF-type relaxation in small mesenteric arteries from rats with streptozotocin-induced diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Mediation of vascular relaxation in epineurial arterioles of the sciatic nerve: effect of diabetes in type 1 and type 2 diabetic rat models.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Impaired vasoreactivity to nitric oxide in experimental diabetic neuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Peroxynitrite mediates diabetes-induced endothelial dysfunction: possible role of Rho kinase activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Diabetes-induced peroxynitrite impairs the balance of pro-nerve growth factor and nerve growth factor, and causes neurovascular injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

A new minimally invasive technique to show nerve ischaemia in diabetic neuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

The neural control of micturition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Influence of age and bladder dysfunction on the contractile properties of isolated human detrusor smooth muscle

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Afferent nerve regulation of bladder function in health and disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Neural control of the lower urinary tract: peripheral and spinal mechanisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Adreno-muscarinic synergy in the bladder trigone: calcium-dependent and -independent mechanisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Clinical and experimental aspects of Adreno-muscarinic synergy in the bladder base and prostate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

ATP is released from rabbit urinary bladder epithelial cells by hydrostatic pressure changes--a possible sensory mechanism?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Release of ATP from rat urinary bladder mucosa: role of acid, vanilloids and stretch

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Non-neuronal cholinergic system in human bladder urothelium

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Inhibition of stretching-evoked ATP release from bladder mucosa by anticholinergic agents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Modulation of spontaneous activity in the overactive bladder: the role of P2Y agonists.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Management of detrusor dysfunction in the elderly: changes in acetylcholine and adenosine triphosphate release during aging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Augmented extracellular ATP signaling in bladder urothelial cells from patients with interstitial cystitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Enhanced Adenosine Triphosphate Release From the Urothelium of Patients With Painful Bladder Syndrome: A Possible Pathophysiological Explanation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Physiology of penile erection and pathophysiology of erectile dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Evolution in the concept of erection anatomy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Mechanisms of penile erection and basis for pharmacological treatment of erectile dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Central mechanisms of erectile dysfunction: what a clinician may want to know

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Erectile physiological and pathophysiological pathways involved in erectile dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Nitrergic-noradrenergic interaction in penile erection: a new insight into erectile dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Nitrergic control of peripheral sympathetic responses in the human corpus cavernosum: a comparison with other species.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Neuronal and non-neuronal modulation of sympathetic neurovascular transmission

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Lower urinary tract symptoms and sexual dysfunction: epidemiology and pathophysiology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Alpha-adrenoceptors are a common denominator in the pathophysiology of erectile function and BPH/LUTS--implications for clinical practice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Characterization of phosphodiesterase type 5 expression and functional activity in the human male lower urinary tract

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Nitric Oxide as a Mediator of Relaxation of the Corpus Cavernosum in Response to Nonadrenergic, Noncholinergic Neurotransmission

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Nitric oxide in the penis--science and therapeutic implications from erectile dysfunction to priapism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Nitric oxide/cGMP-mediated effects in the outflow region of the lower urinary tract--is there a basis for pharmacological targeting of cGMP?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Phosphodiesterase 5 in the female pig and human urethra: morphological and functional aspects.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Mechanism of action of PDE5 inhibitors in LUTS and ED: the NO-cGMP pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Distribution of nitric oxide synthase-immunoreactive nerves and identification of the cellular targets of nitric oxide in guinea-pig and human urinary bladder by cGMP immunohistochemistry

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

The nitric oxide pathway in the human prostate: clinical implications in men with lower urinary tract symptoms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Signalling pathways involved in sildenafil-induced relaxation of human bladder dome smooth muscle

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Inhibition of phosphodiesterases relaxes detrusor smooth muscle via activation of the large-conductance voltage- and Ca²⁺-activated K⁺ channel

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Testosterone regulates smooth muscle contractile pathways in the rat prostate: emphasis on PDE5 signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Cyclic nucleotide metabolism including nitric oxide and phosphodiesterase-related targets in the lower urinary tract

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Immunohistochemical distribution of cAMP- and cGMP-phosphodiesterase (PDE) isoenzymes in the human prostate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Effects of phosphodiesterase inhibitors on tension induced by norepinephrine and accumulation of cyclic nucleotides in isolated human prostatic tissue

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Characterization and functional role of androgen-dependent PDE5 activity in the bladder

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Expression of three isoforms of cGMP-binding cGMP-specific phosphodiesterase (PDE5) in human penile cavernosum

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Distribution of phosphodiesterase type 5 (PDE5) in the lateral wall of the guinea pig urinary bladder.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Interstitial cells in the urinary bladder--localization and function.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Contractile activity of the bladder urothelium/lamina propria and its regulation by nitric oxide.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Phosphodiesterase-5 expression and function in the lower urinary tract: a critical review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Combination of alfuzosin and tadalafil exerts an additive relaxant effect on human detrusor and prostatic tissues in vitro.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Integrative control of the lower urinary tract: preclinical perspective

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Nitric oxide/cyclic guanosine monophosphate signalling mediates an inhibitory action on sensory pathways of the micturition reflex in the rat.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Nitric oxide based influence of nitrates on micturition in patients with benign prostatic hyperplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Pre-clinical evidence for the use of phosphodiesterase-5 inhibitors for treating benign prostatic hyperplasia and lower urinary tract symptoms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Cavernous neurotomy in the rat is associated with the onset of an overt condition of hypogonadism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Effect of sildenafil administration on penile hypoxia induced by cavernous neurotomy in the rat.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

ORIGINAL RESEARCH—BASIC SCIENCE: Effect of Chronic Tadalafil Administration on Penile Hypoxia Induced by Cavernous Neurotomy in the Rat

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Randomized, double-blind, placebo-controlled study of postoperative nightly sildenafil citrate for the prevention of erectile dysfunction after bilateral nerve-sparing radical prostatectomy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Sexual rehabilitation and cancer survivorship: a state of art review of current literature and management strategies in male sexual dysfunction among prostate cancer survivors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

A systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with α-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized, double-blind trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Tadalafil relieves lower urinary tract symptoms secondary to benign prostatic hyperplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Tadalafil 2.5 or 5 mg administered once daily for 12 weeks in men with both erectile dysfunction and signs and symptoms of benign prostatic hyperplasia: results of a randomized, placebo-controlled, double-blind study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Monotherapy with tadalafil or tamsulosin similarly improved lower urinary tract symptoms suggestive of benign prostatic hyperplasia in an international, randomised, parallel, placebo-controlled clinical trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a 1-year, open-label extension study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Urodynamic effects of the combination of tamsulosin and daily tadalafil in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia: a randomized, placebo-controlled clinical trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

A randomized, placebo-controlled study to assess safety and efficacy of vardenafil 10 mg and tamsulosin 0.4 mg vs. tamsulosin 0.4 mg alone in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Evaluation of the effect of sildenafil and/or doxazosin on Benign prostatic hyperplasia-related lower urinary tract symptoms and erectile dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Tadalafil for the treatment of benign prostatic hyperplasia: when the moment does not add up

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.53

Characterization and functional relevance of cyclic nucleotide phosphodiesterase isoenzymes of the human prostate

31 March 2020

1 reference

12 December 2020

Urethra is more sensitive to ischemia than bladder: evidence from an in vitro rat study

1 reference

12 December 2020

Influence of aging on peripheral nerve function and regeneration.

1 reference

12 December 2020

The synthesis and release of prostaglandins by human urinary bladder muscle in vitro

1 reference

12 December 2020

The role of M2 muscarinic receptor subtypes mediating contraction of the circular and longitudinal smooth muscle of the pig proximal urethra

1 reference

12 December 2020

Reflex pathways controlling urethral striated and smooth muscle function in the male rat.

1 reference

12 December 2020

Local mechanisms of blood flow control by perivascular nerves and endothelium

1 reference

12 December 2020

Adrenergic- and capsaicin-evoked nitric oxide release from urothelium and afferent nerves in urinary bladder

1 reference

12 December 2020

Nitric oxide synthase and the lower urinary tract: possible implications for physiology and pathophysiology.

1 reference

12 December 2020

Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses

1 reference

12 December 2020

Pharmacology of phosphodiesterase-5 inhibitors.

1 reference

12 December 2020

Effect of anoxia on the urethral response to phenylephrine.

1 reference

12 December 2020

Vardenafil for treatment of men with erectile dysfunction: efficacy and safety in a randomized, double-blind, placebo-controlled trial.

1 reference

12 December 2020

Overactivity and structural changes in the chronically ischemic bladder.

1 reference

12 December 2020

Endothelial dysfunction in erectile dysfunction: role of the endothelium in erectile physiology and disease

1 reference

12 December 2020

Effects of isosorbide dinitrate on the urinary flow rate in patients with benign prostatic hyperplasia

1 reference

12 December 2020

The association between lower urinary tract symptoms and erectile dysfunction in four centres: the UrEpik study

1 reference

12 December 2020

Pharmacology of lower urinary tract smooth muscles and penile erectile tissues.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRUROL.2014.53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24619381%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1 reference